These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10468324)

  • 1. Predicting response: serotonin reuptake inhibition.
    Mendlewicz J
    Int Clin Psychopharmacol; 1999 May; 14 Suppl 1():S17-20. PubMed ID: 10468324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects.
    Stahl SM
    J Affect Disord; 1998 Dec; 51(3):215-35. PubMed ID: 10333979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of the pharmacology of serotonin reuptake inhibitors.
    Warrington SJ
    Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():13-9. PubMed ID: 1484174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fluoxetine: an update of its use in major depressive disorder in adults].
    Gourion D; Perrin E; Quintin P
    Encephale; 2004; 30(4):392-9. PubMed ID: 15597466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SSRIs and SNRIs: broad spectrum of efficacy beyond major depression.
    Gorman JM; Kent JM
    J Clin Psychiatry; 1999; 60 Suppl 4():33-8; discussion 39. PubMed ID: 10086481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review.
    Vaswani M; Linda FK; Ramesh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):85-102. PubMed ID: 12551730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression.
    Geddes JR; Freemantle N; Mason J; Eccles MP; Boynton J
    Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD001851. PubMed ID: 17636689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.
    Finley PR
    Ann Pharmacother; 1994 Dec; 28(12):1359-69. PubMed ID: 7696728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
    Gunasekara NS; Noble S; Benfield P
    Drugs; 1998 Jan; 55(1):85-120. PubMed ID: 9463792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression.
    Mace S; Taylor D
    Expert Opin Pharmacother; 2000 Jul; 1(5):917-33. PubMed ID: 11249500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Where are we going with SSRIs?
    Isaac M
    Eur Neuropsychopharmacol; 1999 Jul; 9 Suppl 3():S101-6. PubMed ID: 10523065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do antidepressants affect serotonin receptors? The role of serotonin receptors in the therapeutic and side effect profile of the SSRIs.
    Goodwin GM
    J Clin Psychiatry; 1996; 57 Suppl 4():9-13. PubMed ID: 8636065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability and safety of fluvoxamine and other antidepressants.
    Westenberg HG; Sandner C
    Int J Clin Pract; 2006 Apr; 60(4):482-91. PubMed ID: 16620364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.
    von Wolff A; Hölzel LP; Westphal A; Härter M; Kriston L
    J Affect Disord; 2013 Jan; 144(1-2):7-15. PubMed ID: 22963896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severe depression with the selective serotonin reuptake inhibitors.
    Schatzberg AF
    Depress Anxiety; 1996-1997; 4(4):182-9. PubMed ID: 9166650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of patients with depression associated with anxiety symptoms.
    Nutt D
    J Clin Psychiatry; 1997; 58 Suppl 8():11-6. PubMed ID: 9236730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of antidepressants: selectivity or multiplicity?
    Westenberg HG
    J Clin Psychiatry; 1999; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.